Previous 10 | Next 10 |
Thorne HealthTech to Participate in the 2023 RBC Capital Markets Global Healthcare Conference on May 16 PR Newswire NEW YORK , May 3, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne") (the "Company") (NASDAQ: THRN), a leader in delivering innovative so...
Thorne HealthTech Wins 2023 MedTech Breakthrough Award for Best Overall Medical Device Product for Thorne's OneDraw® Blood Collection Device PR Newswire NEW YORK , May 3, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. ("Thorne") (NASDAQ: THRN), a lea...
Thorne HealthTech Schedules First Quarter 2023 Earnings Release and Conference Call PR Newswire NEW YORK , May 1, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. (NASDAQ: THRN ), a leader in delivering innovative solutions for a personalized approach to health a...
2023-04-12 03:39:05 ET Summary THRN has been growing the top and bottom lines, but faces headwinds that are probably going to slow down its growth trajectory. Adding to an existing facility and building a new one is going to put downward pressure on its margins going forward. ...
2023-04-04 16:37:31 ET Thorne HealthTech ( THRN ) on Tuesday announced significant positive findings from a placebo-controlled trial testing SynaQuell, a multi-ingredient nutritional supplement that supports healthy brain structure. The trial, which was done in collaboration with ...
THORNE HEALTHTECH SHARES RESULTS OF COLLABORATIVE CLINICAL TRIAL WITH MAYO CLINIC AND HEALTHTECH CONNEX, INC. - "THE EFFECTS OF A DIETARY SUPPLEMENT ON BRAIN FUNCTION AND STRUCTURE IN JUNIOR A ICE HOCKEY PLAYERS" PR Newswire Significant positive findings from a double-blinded,...
2023-03-31 17:52:33 ET The following slide deck was published by Thorne HealthTech, Inc. in conjunction with their 2022 Q4 earnings call. For further details see: Thorne HealthTech, Inc. 2022 Q4 - Results - Earnings Call Presentation
2023-03-31 16:57:06 ET Thorne HealthTech, Inc. (THRN) Q4 2022 Earnings Conference Call March 31, 2023 8:00 AM ET Company Participants Thomas Wilson – Vice President-Investor Relations Paul Jacobson – Chief Executive Officer Michelle Crow – Ch...
2023-03-31 00:39:13 ET Thorne HealthTech press release ( NASDAQ: THRN ): Q4 Non-GAAP EPS of $0.13 misses by $0.03 . Revenue of $62.96M (+27.7% Y/Y) misses by $0.95M . For further details see: Thorne HealthTech Non-GAAP EPS of $0.13 misses by $0.03, revenu...
Thorne HealthTech Reports Fourth Quarter and Full-Year 2022 Results PR Newswire Net Sales Growth of 24.1% and Adj. EBITDA 1 growth of 19.1% for Full-Year 2022; Provides Full-Year 2023 Guidance NEW YORK , March 30, 2023 /PRNewswire/ -- Thorne HealthTec...
News, Short Squeeze, Breakout and More Instantly...
Thorne Healthtech Inc. Company Name:
THRN Stock Symbol:
NASDAQ Market:
Thorne Healthtech Inc. Website:
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...
Thorne Healthtech Inc. (THRN) is expected to report for Q3 2023
L Catterton Completes Acquisition of Thorne HealthTech, Inc. PR Newswire NEW YORK , Oct. 16, 2023 /PRNewswire/ -- L Catterton, a leading global consumer-focused investment firm, today announced the successful completion of its acquisition of Thorne ...